This week, we will discuss the PATH BP trial, which demolishes the supposed benign nature of acetaminophen/paracetamol.
NSAIDs (maybe) are nephrotoxic: the Visual Abstract
Stepping up to the plate is Sinead Stoneman again!
This week, we will discuss the clinical significance of eGFRdiff, the difference in eGFRcys (cystatin C) and eGFRcr (creatinine).
This week, we will discuss how the CONFIDENCE trial gets nephrology closer to the magic CKD polypill of CKD.
Summary of the CAPTIVATE platform which will be a twitter spaces discussion
This week, we will discuss a registry trial: can a nationwide nudge fix a CKD treatment gap?
Stepping up to the plate is Sinead Stoneman again!